Tradestie Institutional Equity Comparison Engine

NMR vs IREN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NMR Overall Edge

NMR Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nomura Holdings, Inc (NMR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NMR trades at 12.7x Forward P/E with 25.1% operating margin (+17.9% YoY revenue) versus IREN at 65.4x Forward P/E and -72.9% operating margin (-5.0% YoY). In options structure, NMR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against IREN sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NMR
NMR 12.7x vs IREN 65.4x Fwd P/E
Growth & Margin Winner NMR
Op Margin 25.1% vs -72.9% ยท YoY +17.9% vs -5.0%
Momentum & Technical Winner NMR
1Y +26.3% vs -65.9% ยท 52W Pos 60% vs 1%
Options & Structure Winner NMR
UNCLASSIFIED (<1st %ile IV) vs BREAKDOWN (32nd %ile IV)
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
1M Return +2.36%
1Y Return +26.32%
Forward P/E 12.7x
Unified AI Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
IREN NASDAQ
IREN Limited Ordinary Shares
Finance Services
$15.81
-3.51% 1D
Market Cap $7.7B
1M Return -42.97%
1Y Return -65.89%
Forward P/E 65.4x
Unified AI Score
42.9 / 100 HOLD
Tech 25.0 Fund 44.0 Flow 57.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NMR +26.32% IREN -65.89% Spread: +92.21 pp (NMR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NMR TTM Op. Margin: 25.1% IREN TTM Op. Margin: -72.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs IREN. Trailing 12-month operating profitability (NMR 25.1% vs IREN -72.9%) and valuation multiples (NMR 12.7x vs IREN 65.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NMR (10) vs IREN (0)
Institutional Metric NMR IREN Criterion Row Winner
Market Capitalization Scale $28.3B $7.7B Larger Scale NMR
Trailing P/E Ratio Valuation 11.2x 65.4x Lower Multiple NMR
Forward P/E Ratio Valuation 12.7x 65.4x Lower Multiple NMR
Revenue Growth (YoY) Growth +17.9% -5.0% Higher Growth NMR
Operating Margin (TTM) Profitability 25.1% -72.9% Higher Margin NMR
Net Profit Margin Profitability 17.1% -194.3% Higher Margin NMR
Return on Equity (ROE) Capital Efficiency 11.5% -33.8% Higher ROE NMR
52-Week Range Position Momentum 60% ($7โ€“$11) 1% ($15โ€“$71) Stronger Trend NMR
Beta / 30D Volatility Risk Regime 1.03ฮฒ ยท 29% Vol 3.88ฮฒ ยท 136% Vol Lower Realized Risk NMR
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 42.9 / 100 (HOLD) Higher Composite NMR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NMR vs IREN Buy Guide
NMR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live NMR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IREN BREAKDOWN
121d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live IREN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NMR nor IREN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.